Hepatitis B: Verskil tussen weergawes

Content deleted Content added
k Robot: standardiseer verwysingsjablone en voeg argiefskakels in.
k Robot: standardiseer verwysingsjablone en voeg argiefskakels in.
 
Lyn 33:
 
== Voorkoms ==
Sowat ’n derde van die wêreld se bevolking is in die een of ander stadium van hul lewe aangetas, insluitende 343&nbsp;miljoen wat ’n chroniese infeksie het.<ref name=GBD2015Pre>{{cite journal|last1=GBD 2015 Disease and Injury Incidence and Prevalence|first1=Collaborators.|title=Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.|journal=Lancet|date=8 Oktober 2016|volume=388|issue=10053|pages=1545–1602|pmid=27733282|doi=10.1016/S0140-6736(16)31678-6|pmc=5055577}}</ref><ref name=WHO2014/><ref>{{cite journal | author = Schilsky ML | title = Hepatitis B "360" | journal = Transplantation Proceedings | volume = 45 | issue = 3 | pages = 982–985 | year = 2013 | pmid = 23622604 | pmc = | doi = 10.1016/j.transproceed.2013.02.099 }}</ref> Meer as 750&nbsp;000 mense sterf jaarliks aan {{nowrap|hepatitis B}},<ref name=WHO2014>{{cite web |title=Hepatitis B Fact sheet N°204 |url=http://www.who.int/mediacentre/factsheets/fs204/en/ |website=who.int |access-date=4 November 2014 |date=Julie 2014 |language=en |archive-url=https://web.archive.org/web/20180422034331/http://www.who.int/mediacentre/factsheets/fs204/en/ |archive-date=22 April 2018 |url-status=live |df=dmy-all}}</ref> waarvan 300&nbsp;000 weens lewerkanker is.<ref name=GBD204>{{cite journal|last1=GBD 2013 Mortality and Causes of Death|first1=Collaborators|title=Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013.|journal=Lancet|date=17 Desember 2014|pmid=25530442|doi=10.1016/S0140-6736(14)61682-2|volume=385|issue=9963|pages=117–71|pmc=4340604}}</ref>
 
Die siekte is nou net algemeen in [[Oos-Asië]] en [[Afrika suid van die Sahara]], waar tussen 5% en 10% van volwassenes ’n chroniese infeksie het.<ref name=WHO2014/> In [[Europa]] en [[Noord-Amerika]] is die syfer minder as 1%.<ref name=WHO2014/> Navorsing word gedoen na die moontlike vervaardiging van kos met HBV-inenting.<ref>{{cite book|last1=Thomas|first1=Bruce|title=Production of Therapeutic Proteins in Plants|date=2002|isbn=9781601072542|page=4|url=https://books.google.com/books?id=D-Nj4x9zXi4C&pg=PA4&dq|accessdate=25 November 2014|url-status=live|archiveurl=https://web.archive.org/web/20150928135630/https://books.google.com/books?id=D-Nj4x9zXi4C&pg=PA4&dq|archivedate=28 September 2015|df=dmy-all}}</ref>